Ramona Doyle - Chief Medical Officer at RECURSION PHARMACEUTICALS, INC.

Issuer-level insider activity

Role
Chief Medical Officer
Issuer ticker
RXRX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Ramona Doyle since 25 Aug 2025

Reported holdings for Ramona Doyle in RECURSION PHARMACEUTICALS, INC.

Form 4 holding Chief Medical Officer

RECURSION PHARMACEUTICALS, INC.

Security class
Class A Common Stock
Shares / value
121,110
Estimated value
$1,280,811
Report date
16 May 2022
Price
$10.58
Ownership
Direct

Transaction history for Ramona Doyle in RECURSION PHARMACEUTICALS, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .